NCT00453232View on ClinicalTrials.gov

Combination Chemotherapy and Pegfilgrastim in Treating Men With Metastatic Germ Cell Tumors

PHASE2CompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

August 31, 2004

Primary Completion Date

December 31, 2008

Study Completion Date

January 31, 2009

Conditions
Extragonadal Germ Cell TumorTeratomaTesticular Germ Cell Tumor
Interventions
BIOLOGICAL

bleomycin sulfate

BIOLOGICAL

pegfilgrastim

DRUG

cisplatin

DRUG

etoposide

Trial Locations (7)

CB2 2QQ

Addenbrooke's Hospital, Cambridge

LS9 7TF

Leeds Cancer Centre at St. James's University Hospital, Leeds

EC1A 7BE

Saint Bartholomew's Hospital, London

NE4 6BE

Northern Centre for Cancer Treatment at Newcastle General Hospital, Newcastle upon Tyne

OX3 7LJ

Churchill Hospital, Oxford

EH4 2XU

Edinburgh Cancer Centre at Western General Hospital, Edinburgh

G11 6NT

Beatson West of Scotland Cancer Centre, Glasgow

All Listed Sponsors
lead

Cambridge University Hospitals NHS Foundation Trust

OTHER

NCT00453232 - Combination Chemotherapy and Pegfilgrastim in Treating Men With Metastatic Germ Cell Tumors | Biotech Hunter | Biotech Hunter